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http:WHAT THIS PAPER ADDS
This study has revealed characteristic indocyanine green lymphography patterns in primary leg lymphedema for
the ﬁrst time. Based on indocyanine green lymphography ﬁndings, primary leg lymphedema could be classiﬁed
into four patterns with different patient characteristics, which imply different etiologies of primary lymphedema.
The study provides basic information for further investigation to clarify etiology and prognosis of primary
lymphedema and to develop optimal treatments for primary lymphedema.Objectives: Indocyanine green (ICG) lymphography has been reported to be useful for the evaluation of
secondary lymphedema, but no study has reported characteristic ﬁndings of ICG lymphography in primary
lymphedema. This study aimed to classify characteristic ICG lymphography patterns in primary lymphedema.
Methods: The study was a retrospective observational study. Thirty one primary lower extremity lymphedema
(LEL) patients with a total of 62 legs were studied. ICG lymphography patterns were categorized according to the
visibility of lymphatics and dermal backﬂow (DB) extension. Clinical demographics were compared with
categorized ICG lymphography patterns.
Results: All symptomatic legs showed abnormal patterns, and all asymptomatic legs showed normal patterns on
ICG lymphography. Abnormal lymphographic patterns could be classiﬁed into proximal DB (PDB), distal DB (DDB),
less enhancement (LE), and no enhancement (NE) patterns. There were signiﬁcant differences between PDB (16
patients), DDB (6 patients), LE (4 patients), and NE patterns (5 patients) in age (37.3  18.3 vs. 61.8  19.2 vs.
50.8  27.7 vs. 29.2  18.0 years, p ¼ .035), onset of edema (23.9  19.4 vs. 46.8  27.0 vs. 43.0  31.3 vs.
6.6  14.2 years, p ¼ .020), laterality (bilateral; 18.8% vs. 66.7% vs. 75.0% vs. 0%, p ¼ .016), cellulitis history
(56.3% vs. 100% vs. 25.0% vs. 0%, p ¼ .007), and LEL index (292.2  32.8 vs. 254.2  28.6 vs. 243.3  9.4 vs.
295.2  44.8, p ¼ .016).
Conclusions: ICG lymphography ﬁndings in primary lymphedema could be classiﬁed into four patterns with
different patient characteristics.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Primary lymphedema has a wide variety of etiologies, and
can manifest as a localized or a generalized disease.1e3
Some are proved to be familial with systemic diseases
associated with genetic mutations such as Milroy disease,
but most are solitary and their pathophysiology is yet to be
clariﬁed. Lymphatic malformations such as aplasia, hypo-
plasia, or hyperplasia of lymphatic vessels and/or lymph
nodes or can be a cause of primary lymphedema.4e6 It is
important to clarify the etiology of primary lymphedema for
appropriate management of the disease.rresponding author. Department of Plastic and Reconstructive
, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655,
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//dx.doi.org/10.1016/j.ejvs.2014.10.023Diagnosis of primary lymphedema starts from ruling out
other edematous diseases such as heart failure, nephrosis,
liver cirrhosis, deep vein thrombosis, other venous edema,
and secondary lymphedema. After excluding other edema-
tous diseases, lymphatic imaging is necessary to conﬁrm
abnormal lymph circulation.7e10 Indocyanine green (ICG)
lymphography is becoming a useful option for lymphatic
imaging; ICG lymphography can clearly visualize superﬁcial
lymph ﬂows in real time without radiation exposure.11e15
Pathophysiological severity staging systems have been re-
ported based on ICG lymphography ﬁndings for secondary
peripheral lymphedema, but no study has been reported
regarding ICG lymphography classiﬁcation for primary lym-
phedema.11e16 Although lymphoscintigraphy which can
visualize both superﬁcial and deep lymph ﬂows is consid-
ered a gold standard for primary lymphedema evaluation, it
is important to clarify the characteristic ﬁndings of the
emerging lymph visualization modality of ICG lymphog-
raphy. This study aimed to evaluate and classify ICG
lymphography ﬁndings in primary leg lymphedema.
Table 1. Patient characteristics.
Sixty-two legs of 31 primary LEL patients
Age, yearsa 12e82 (42.5)
Sex
Female 20 (64.5%)
Male 11 (35.5%)
BMI (kg/m2)a 16e36 (23.0)
Laterality
Unilateral LEL 21 (67.7%)
Bilateral LEL 10 (32.3%)
Past history or cellulitis
Yes 16 (51.6%)
No 15 (48.4%)
Onset of LEL (years old)a 0e78 (28.0)
Duration of LEL (years)a 1e52 (14.5)
ISL stage of 41 edematous legs
Stage 1 13 (31.7%)
Stage 2 23 (56.1%)
Stage 3 5 (12.2%)
LEL indexa
Non-edematous legs (n ¼ 21) 176e245 (222.9)
Edematous legs (n ¼ 41) 206e369 (269.1)
Total (n ¼ 62) 176e369 (253.4)
Note. Data are counts (percentages) unless otherwise indicated.
LEL ¼ lower extremity lymphedema; BMI ¼ body mass index;
ISL¼ International Society of Lymphology.
a Data are ranges (averages).
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From June 2009 to January 2013 under the University of
Tokyo Hospital ethics committee approved protocol, ICG
lymphography was performed on 62 legs of 31 consecutive
primary lower extremity lymphedema (LEL) patients. For all
patients included in this study, other possible conditions
such as heart failure, nephrosis, liver cirrhosis, deep vein
thrombosis, endocrinological edema, drug induced edema,
and pelvic cancer were ruled out as causes of patients’ leg
edema by internists, and primary LEL was suspected (Fig. 1).
No patients suffered from arterial and/or venous malfor-
mation, nor generalized lymphedema. No patients had al-
lergy to iodine: ICG injection is contraindicated for patients
with iodine allergy. Of 31 primary LEL patients, 20 were
female (64.5%), 16 had past history of leg cellulitis (51.6%),
and 10 suffered from bilateral LEL (32.3%); there were 21
normal legs, 21 unilateral and 20 bilateral lymphedematous
legs, with a total of 41 lymphedematous legs. No patients
had a family history of lymphedema. The patients’ age
ranged from 12 to 82 years (average, 42.5 years), body mass
index (BMI) from 16 to 36 kg/m2 (average, 23.0 kg/m2),
onset of edema from 0 to 78 years (average, 28.0 years),
and duration of edema from 1 to 52 years (average, 14.5
years). Of 41 lymphedematous legs, 13 were diagnosed as
International Society of Lymphology (ISL) stage 1 lymphe-
dema, 23 as ISL stage 2, and 5 as ISL stage 3.17 The LEL
index, body type corrected leg volume evaluation, ranged
from 176 to 369 (average, 253.4). Asymptomatic legs
showed no objective edema on physical examination, and
the LEL index ranged from 176 to 245 (average 222.9) in 21
asymptomatic legs, and from 206 to 369 (average 269.1) in
41 symptomatic legs (Table 1 and Appendix 1).18
ICG lymphography was performed as follows: 0.2 ml of
ICG (Diagnogreen 0.25%; Daiichi Pharmatical, Tokyo, Japan)
was injected subcutaneously into both lower extremities at
the ﬁrst web space of the foot and the lateral border of the
Achilles tendon.11,14,15 After injection, circumferential ﬂuo-
rescent images of lymphatic drainage channels wereFigure 1. Evaluation of leg edema. Possible edematous conditions
other than primary lymphedema are ruled out by internists before
evaluation using indocyanine green lymphography.obtained using an infrared camera system (Photodynamic
Eye [PDE]; Hamamatsu Photonics K.K., Hamamatsu,
Japan) (Appendix 2). ICG lymphography images were
recorded at a plateau phase of the lymphography (12 to
18 h after injection).
Visual interpretation of ICG lymphography
ICG lymphography ﬁndings of primary LEL patients are
classiﬁed into two large groups: normal and abnormal
patterns. Normal lymphography pattern is deﬁned as fol-
lows: superﬁcial lymphatic vessels are visualized as a linear
pattern from the injection sites to the superﬁcial inguinal
lymph nodes except in regions with thick layers of fat, such
as the thigh, where images cannot be clearly visualized.
Abnormal lymphography pattern is deﬁned as: DB patterns
are seen or visibility of enhanced lymphatics is apparently
deteriorated. According to extension of DB patterns and
visibility of enhanced lymphatics, abnormal lymphography
pattern is subdivided into four sub-patterns: proximal DB
(PDB), distal DB (DDB), less enhancement (LE), and no
enhancement (NE) patterns. In the PDB pattern, the DB
pattern extends from the groin to the distal region, and
linear pattern is shown distal to the extension of the DB
patterns (Fig. 2). In the DDB pattern, the DB pattern is
observed in the distal part of the lower extremity but not in
the groin, and the remaining region shows linear pattern or
no enhanced images (Fig. 3). In the LE pattern, the linear
pattern is observed only in the distal part of the lower ex-
tremity, and the remaining proximal part shows no
enhanced image; no DB pattern is observed (Fig. 4). In the
NE pattern, no enhanced lymphatic image is observed other
Figure 2. Proximal dermal backﬂow (PDB) pattern. (A) Left leg primary lymphedema. (B) On indocyanine green lymphography, dermal
backﬂow extends from the left groin to the left lower leg (PDB pattern). Linear pattern is observed in the whole right leg (normal pattern).
(C) Enhanced lymphatics are yellow.
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DB pattern (Fig. 5).
All ICG lymphography images were reviewed by two in-
dependent observers (2 plastic surgeons) to analyze ICGFigure 3. Distal dermal backﬂow (DDB) pattern. (A) Left leg primary
backﬂow pattern is observed distal to the left knee (DDB pattern). Line
Enhanced lymphatics are yellow.lymphography ﬁndings.11 Characteristic patterns were then
categorized, and clinical demographics were compared with
categorized ICG lymphography patterns (pluseminus value
expressed mean  standard deviation). Analysis of variancelymphedema. (B) On indocyanine green lymphography, dermal
ar pattern is observed in the whole right leg (normal pattern). (C)
Figure 4. Less enhancement (LE) pattern. (A) Bilateral leg primary lymphedema. (B) Indocyanine green lymphography shows linear pattern
only in the bilateral lower legs, and the remaining proximal part shows no enhanced image (LE pattern). (C) Enhanced lymphatics are
yellow.
Figure 5. No enhancement (NE) pattern. (A) Left leg congenital lymphedema. (B) On indocyanine green lymphography, no enhanced
lymphatic image is observed in the left leg other than the dorsum of the left foot where indocyanine green was injected (NE pattern).
Linear pattern is observed in the whole right leg (normal pattern). (C) Enhanced lymphatics are yellow.
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categorical variables. Statistical signiﬁcance was deﬁned as
p < .05. All patients gave written consent to this study.
RESULTS
There was no difference in ICG lymphography pattern
categorization between the two independent observers. All
21 non-edematous legs were asymptomatic with a normal
ICG lymphography pattern, and all 41 edematous legs were
symptomatic with one of the abnormal ICG lymphography
patterns; speciﬁcity was 100% (21/21), and sensitivity was
100% (41/41). Patient characteristics according to ICG
lymphography patterns are shown in Table 2.
The PDB pattern was seen in 19 legs of 16 patients on ICG
lymphography. Only one of 16 patients had developed leg
edema at birth.
The DDB pattern was seen in 10 legs of six patients; nine
legs showed the DB pattern distal to the knee, and one leg
showed the DB pattern in the thigh and the lower leg.
Onset of edema was after 35 years in ﬁve of six patients. All
patients had past history of leg cellulitis.
The LE pattern was seen in seven legs of four patients on
ICG lymphography. No patients had developed leg edema at
birth.
The NE pattern was seen in ﬁve legs of ﬁve patients on
ICG lymphography. Onset of edema was at birth in three of
ﬁve patients. No patients had past history of leg cellulitis.
There were signiﬁcant differences among the PDB, DDB,
LE, and NE patterns in age (37.3  18.3 vs. 61.8  19.2 vs.
50.8  27.7 vs. 29.2  18.0 years, p ¼ .035), onset of
edema (23.9  19.4 vs. 46.8  27.0 vs. 43.0  31.3 vs.
6.6  14.2 years, p ¼ .020), laterality of lymphedemaTable 2. Comparison of patient characteristics between ICG lymphogr
ICG lymphography pattern
PDB DDB
n ¼ 16 n ¼ 6
Age, yearsa 37.3  18.3 61.8  19.
Sex
Female 9 (56.3%) 4 (66.7%)
Male 7 (43.7%) 2 (33.3%)
BMI (kg/m2)a 21.5  3.1 23.6  3.2
Laterality
Unilateral LEL 13 (81.2%) 2 (33.3%)
Bilateral LEL 3 (18.8%) 4 (66.7%)
Past history of cellulitis
Yes 9 (56.3%) 6 (100%)
No 7 (43.7%) 0 (0%)
Onset of LEL (years)a 23.9  19.4 46.8  27.
Duration of LEL (years)a 13.4  13.2 15.0  16.
ISL stage
Stage 1 4 (25.0%) 1 (16.7%)
Stage 2 10 (62.5%) 5 (83.3%)
Stage 3 2 (12.5%) 0 (0%)
LEL indexa 292.2  32.8 254.2  28
Note. Data are counts (percentages) unless otherwise indicated. ICG ¼
dermal backﬂow; LE ¼ less enhancement; NE ¼ no enhancement;
ISL¼ International Society of Lymphology.*p < .05.
a Data are means  standard deviations.(bilateral LEL; 18.8% vs. 66.7% vs. 75.0% vs. 0%, p ¼ .016),
past history of cellulitis (56.3% vs. 100% vs. 25.0% vs. 0%,
p ¼ .007), and LEL index (292.2  32.8 vs. 254.2  28.6 vs.
243.3  9.4 vs. 295.2  44.8, p ¼ .016). There was no
signiﬁcant difference among PDB, DDB, LE, and NE patterns
in BMI (21.5  3.1 vs. 23.6  3.2 vs. 25.7  7.4 vs.
25.1  6.2, p ¼ .216), Sex (female; 56.3% vs. 66.7% vs.
75.0% vs. 80.0%, p ¼ .752), duration of edema (13.4  13.2
vs. 15.0  16.6 vs. 7.8  10.3 vs. 22.6  12.9, p ¼ .425), or
ISL stage (stage 1/2/3; 4/10/2 vs. 1/5/0 vs. 3/1/0 vs. 1/2/2,
p ¼ .155).
DISCUSSION
In the present study, all asymptomatic legs demonstrated a
normal ICG lymphography pattern, and all symptomatic legs
demonstrated abnormal ICG lymphography patterns, which
indicated that ICG lymphography was highly sensitive and
speciﬁc to detect abnormal lymph circulation. This study
revealed that an abnormal lymph circulatory pattern in
primary LEL could be classiﬁed into the following four pat-
terns: PDB, DDB, LE, and NE. According to the ICG
lymphography patterns, there were signiﬁcant differences in
patient characteristics such as age, onset of edema, later-
ality of lymphedema, past history of cellulitis, and lym-
phedematous volume.
Since PDB pattern is similar to ICG lymphography ﬁndings
in obstructive LEL secondary to pelvic cancer or its treat-
ments, malignancy should be ruled out ﬁrst as a cause of
lymph ﬂow obstruction in patients with the PDB
pattern.10,11,14,15 In this study, all patients had already un-
dergone a work up for ruling out edematous diseases other
than primary lymphedema. Thus, lymphatic obstruction dueaphy patterns.
p
LE NE
n ¼ 4 n ¼ 5
2 50.8  27.7 29.2  18.0 .035*
.752
3 (75.0%) 4 (80.0%)
1 (25.0%) 1 (20.0%)
25.7  7.4 25.1  6.2 .216
.016*
1 (25.0%) 5 (100%)
3 (75.0%) 0 (0%)
.007*
1 (25.0%) 0 (0%)
3 (75.0%) 5 (100%)
0 43.0  31.3 6.6  14.2 .020*
6 7.8  10.3 22.6  12.9 .425
.155
3 (75.0%) 1 (20.0%)
1 (25.0%) 2 (40.0%)
0 (0%) 2 (40.0%)
.6 243.3  9.4 295.2  44.8 .016*
indocyanine green; PDB ¼ proximal dermal backﬂow; DDB ¼ distal
BMI ¼ body mass index; LEL ¼ lower extremity lymphedema;
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or both) in the inguinal or more cranial region may be a
cause of primary LEL.4e6,10,19e21 As there was only one
congenital case of the 16 cases, severe aplasia that could
manifest symptomatic lymphedema at birth would not be a
dominant cause of LEL in patients with the PDB pattern in
this study.
In the DDB pattern, the DB pattern is also seen, which
indicates an obstructive mechanism as a cause of the LEL, as
in the PDB pattern.10e15 A major difference between the
PDB and the DDB patterns is that the DDB pattern shows
the DB pattern only in the distal region (distal to the
inguinal lymph nodes). Thus, lymphatic obstruction due to
malformation of the lymphatic vessels distal to the inguinal
lymph nodes may be a cause of primary LEL. As all patients
with the DDB pattern had a past history of cellulitis,
lymphatic inﬂammation may have affected progression of
LEL.1e3,22
The LE pattern does not show the DB pattern, which
indicates there is no, or mild, obstructive mechanism that
will cause lymph extravasation from lymphatic vessels.10e15
Mild lymphatic malformation that reduces lymph pump
function but not enough to cause lymph extravasation, such
as lymphatic endoluminal valvular malformation, would
contribute to development of LEL.5,6 No patients with the
LE pattern had developed LEL at birth in the study. Since the
lymph pump function devolves with aging, aging in the
setting of primary “subclinical” lymphatic dysfunction may
be one of the causes; when lymphatic dysfunction reached
a critical point to manifest symptomatic lymphedema due
to aging in addition to lymphatic malformation, a patient
will develop symptomatic lymphedema after birth.23,24
The NE pattern shows no enhanced lymphatics, which
indicates severe lymphatic abnormality such as whole limb
lymphatic aplasia, severe hypoplasia, and severe malab-
sorption of lymph.4e6,10 Since all patients had unilateral LEL
and three of ﬁve patients developed LEL at birth, congenital
segmental lymphatic aplasia may be one of the causes.4,10
Although no patients had a past history of leg cellulitis,
patients with the NE pattern were likely to have more se-
vere leg lymphedema than those with other ICG lymphog-
raphy patterns in the present study. In terms of suspected
mechanism and clinical features, LEL with the NE pattern is
the most challenging entity of primary LEL.
As categorized according to abnormal lymph circulation,
the ICG lymphography classiﬁcation of primary lymphe-
dema has a potential to be useful not only for under-
standing etiology or pathophysiology of primary
lymphedema, but also for management of primary lym-
phedema. As in secondary lymphedema, conservative
therapies are the mainstay of primary lymphedema treat-
ments, and further surgical treatments are required for
progressive lymphedema refractory to conservative treat-
ments.25,26 If an obstructive mechanism is suspected, as in
the PDB and DDB patterns, lymphatic bypass would be a
useful treatment option, which addresses the pathophysi-
ology of lymphedema with lymph ﬂow obstruction.27e30 If
lymphatic aplasia is suspected, as in the NE pattern,lymphatic bypass would be impossible and vascularized
lymph node transfer and/or debulking surgery would be
more appropriate.26,31,32 Outcome studies are required to
conﬁrm the usefulness of the classiﬁcation for lymphedema
management.
Classiﬁcation according to onset age is the most
commonly used classiﬁcation of primary lymphedema, in
which primary lymphedema is classiﬁed into congenital
lymphedema, lymphedema praecox, and lymphedema
tarda.1e6,10,19e21 Ages of 0 and 35 are used to categorize
the classiﬁcation, but the criteria do not rely on the path-
ophysiology of primary lymphedema. Some primary lym-
phedemas have been classed as genetic disorders, such as
Milroy’s disease, lymphedema distichiasis syndrome, and
Hennekam’s syndrome, but most are not caused by a single
genetic mutation; many factors are considered to
contribute to lymphatic abnormalities resulting in primary
lymphedema, such as aplasia, hypoplasia, and hyperplasia
of lymphatic vessels and/or lymph nodes.1e6,19e21,33,34
Thus, lymphatic imaging is important for evaluation of pri-
mary lymphedema.10
Although ICG lymphography could classify primary lym-
phedema into four patterns with different characteristics,
there are several drawbacks in the present study. First, ICG
lymphography can visualize only superﬁcial lymph ﬂows.11e
15,27,30 Lymphoscintigraphy and magnetic resonance
lymphography are more appropriate for evaluation of deep
lymph ﬂows, and magnetic resonance, computed tomog-
raphy, and ultrasonography are useful to evaluate subcu-
taneous tissue components.8e10,35,36 Combined imaging
studies are required for thorough lymph ﬂow evaluation of
primary lymphedema. Second, the number of examinees is
relatively small. Since primary lymphedema seems to have a
wide variety of etiologies, other patterns may be observed
in other primary lymphedema patients. Third, this study
included only primary LEL patients. Characteristic ICG
lymphography ﬁndings on primary arm lymphedema, pri-
mary facial lymphedema, and primary systemic lymphe-
dema have not been clariﬁed by the present study.
To our knowledge, this is the ﬁrst report of characteristic
ICG lymphography ﬁndings and ICG lymphography classiﬁ-
cation for primary LEL. Further studies are required to
conﬁrm the validity and usefulness of the classiﬁcation.CONCLUSIONS
All symptomatic legs showed abnormal patterns, and all
asymptomatic legs showed the normal pattern on ICG
lymphography. ICG lymphography ﬁndings in primary lym-
phedema could be classiﬁed into four patterns: PDB, DDB,
LE, and NE patterns. Since patient characteristics are
different, different ICG lymphography patterns indicate
different mechanisms of primary lymphedema and different
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